FHL2 and hypertrophic cardiomyopathy: Evidence shows that FHL2 protein levels are lower in patients with hypertrophic cardiomyopathy (HCM), and FHL2 overexpression protects phenylephrine- or endothelin-1-induced hypertrophy in cardiac myocytes (Friedrich et al., 2014).